Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011.

PubWeight™: 1.76‹?› | Rank: Top 3%

🔗 View Article (PMID 21427259)

Published in Perit Dial Int on March 23, 2011

Authors

Peter G Blake1, Joanne M Bargman, K Scott Brimble, Sara N Davison, David Hirsch, Brendan B McCormick, Rita S Suri, Paul Taylor, Nadia Zalunardo, Marcello Tonelli, Canadian Society of Nephrology Work Group on Adequacy of Peritoneal Dialysis

Author Affiliations

1: Division of Nephrology,1 University of Western Ontario, London, Ontario, Canada. peter.blake@lhsc.on.ca

Articles citing this

Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada. Clin J Am Soc Nephrol (2012) 1.14

Peritoneal dialysis in children with end-stage renal disease. Nat Rev Nephrol (2011) 0.88

Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period. Perit Dial Int (2013) 0.80

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients. PLoS One (2015) 0.79

Novel predictors of peritonitis-related outcomes in the BRAZPD cohort. Perit Dial Int (2014) 0.77

Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study. BMC Nephrol (2017) 0.75

Encapsulating Peritoneal Sclerosis - A rare and serious complication of peritoneal dialysis: Case series. J Med Life (2014) 0.75

Management of a rapidly growing peritoneal dialysis population at the First Affiliated Hospital of Sun Yat-sen University. Perit Dial Int (2014) 0.75

Bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients. Int J Nephrol (2013) 0.75

Impact of gender and dialysis adequacy on anaemia in peritoneal dialysis. Int Urol Nephrol (2017) 0.75

A contribution from Canada. Perit Dial Int (2011) 0.75

Cyclic pseudoperitonitis secondary to endometriosis in a peritoneal dialysis patient. Perit Dial Int (2012) 0.75

Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients. Clin Kidney J (2015) 0.75

The peritoneal equilibration test should be included in routine monitoring of peritoneal dialysis patients. Perit Dial Int (2012) 0.75

The Use of Incremental Peritoneal Dialysis in a Large Contemporary Peritoneal Dialysis Program. Can J Kidney Health Dis (2016) 0.75

Value of bioimpedance analysis estimated "dry weight" in maintenance dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol (2017) 0.75

[Peritoneal dialysis from the beginnings up to today: which developments of the last decades were important?]. Wien Med Wochenschr (2013) 0.75

Articles by these authors

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 37.66

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26

Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int (2011) 6.21

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension (2011) 5.14

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10

Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ (2011) 4.68

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45

Recommendations on screening for cervical cancer. CMAJ (2013) 3.32

Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26

Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol (2003) 3.20

Early recognition and prevention of chronic kidney disease. Lancet (2010) 3.19

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med (2011) 3.13

Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int (2005) 3.03

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA (2003) 2.97

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97

Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int (2008) 2.88

Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84

Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA (2010) 2.61

Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58

Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int (2008) 2.56

Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54

Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med (2011) 2.48

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43

Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int (2013) 2.42

Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA (2012) 2.38

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2007) 2.38

Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int (2004) 2.37

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32

Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int (2005) 2.29

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29

Predictive adaptive responses to maternal high-fat diet prevent endothelial dysfunction but not hypertension in adult rat offspring. Circulation (2004) 2.28

Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int (2002) 2.24

Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA (2008) 2.22

Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22

Population based screening for chronic kidney disease: cost effectiveness study. BMJ (2010) 2.19

CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis (2009) 2.17

Proteinuria and life expectancy. Am J Kidney Dis (2012) 2.16

Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol (2012) 2.15

Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol (2011) 2.13

Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13

Impact of anemia on hospitalization and mortality in older adults. Blood (2006) 2.07

Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol (2011) 2.07

Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis: a systematic review and meta-analysis for a Canadian Society of Nephrology clinical practice guideline. Am J Kidney Dis (2013) 2.07

Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol (2008) 2.06

Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med (2008) 2.06

Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res (2005) 2.05

Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant (2012) 2.01

Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91

Chronic kidney disease and life expectancy. Nephrol Dial Transplant (2012) 1.90

Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int (2010) 1.89

Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol (2011) 1.89

Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol (2012) 1.88

Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc (2004) 1.85

Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85

Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.84

Early dialysis initiation and rates and timing of withdrawal from dialysis in Canada. Clin J Am Soc Nephrol (2012) 1.80

The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch Intern Med (2009) 1.77

Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care. CMAJ (2015) 1.77

NSAID use and progression of chronic kidney disease. Am J Med (2007) 1.75

Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol (2006) 1.74

Economic evaluation of sevelamer in patients with end-stage renal disease. Nephrol Dial Transplant (2007) 1.73

Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol (2011) 1.70

Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev Cell (2002) 1.67

Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol (2013) 1.65

Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer? Oncologist (2012) 1.65

Recruitment and training for home hemodialysis: experience and lessons from the Nocturnal Dialysis Trial. Clin J Am Soc Nephrol (2010) 1.64

Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study. Radiology (2005) 1.63

Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney Int (2011) 1.63

Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol (2011) 1.61

Dialysis modality choices among chronic kidney disease patients: identifying the gaps to support patients on home-based therapies. Int Urol Nephrol (2010) 1.61

Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol (2007) 1.60

Kidney stones and kidney function loss: a cohort study. BMJ (2012) 1.58

Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A (2005) 1.57

A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.57

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.55

The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis. CMAJ (2011) 1.54

Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol (2004) 1.53

Survival among patients with kidney failure in Jalisco, Mexico. J Am Soc Nephrol (2007) 1.53

Statins for treatment of dyslipidemia in chronic kidney disease. Perit Dial Int (2006) 1.53